FDA granted orphan drug status to tazemetostat, an EZH2 inhibitor developed by Epizyme Inc., for malignant rhabdoid tumors.
ESPN’s 2015 Jimmy V Week for Cancer Research raised $3.2 million for The V Foundation for Cancer Research—a million more than the $2.2 million raised in 2014. In nine years, Jimmy V Week has raised $13.7 million for cancer research. Jimmy V Week ran from Dec. 2-8, 2015 and introduced the awareness campaign Your Fight... […]
THE MIAMI CANCER INSTITUTE at Baptist Health South Florida joined the Memorial Sloan Kettering Cancer Alliance, making it the third health care system to enlist in the national collaboration.
THE BONNIE J. ADDARIO Lung Cancer Foundation launched the second phase of its Clinical Trial Innovation Prize crowdsourcing challenge in honor of World Cancer Day. The goal of the challenge is to produce breakthroughs that will double the patient accrual rate of clinical trials evaluating interventions in the diagnosis and treatment of all cancers. “The... […]
THE AMERICAN UROLOGICAL ASSOCIATION, the Urology Care Foundation and Chesapeake Urology Associates formed a $1 million partnership, establishing the Community-Based Research to Advance Prostate Cancer Care program. The program will involve data from community urology practices; helping urologists develop research partnerships and collaborations; scholarships for urologists and academic physician-scientists and researchers; services such as study... […]
PAUL VANVELDHUISEN was named chief operating officer of The Emmes Corporation. VanVeldhuisen will continue to serve as principal investigator for government and privately funded research projects. VanVeldhuisen joined the company in 1993 and was promoted to vice president in 2006. He is responsible for the scientific aspects of various research studies, including study design and... […]
PAT KEEL was appointed chief financial officer of St. Jude Children’s Research Hospital. Keel was most recently with University Health System in Shreveport, Louisiana, where she served as chief financial officer and senior vice president. In addition, she held leadership roles with Good Shepherd Health System in Longview, Texas and CHRISTUS Schumpert Health System in... […]
THE UNIVERSITY OF MIAMI Sylvester Comprehensive Cancer Center created two endowed chairs in head and neck oncology. These are the first two chairs of the “100 New Talents for 100 Years” initiative announced by President Julio Frenk at his inauguration address. The W. Jarrard Goodwin Jr., M.D., Endowed Chair in Head and Neck Oncology Surgery... […]
FDA granted orphan drug designation to antifungal drug candidate CD101 IV, developed by Cidara Therapeutics Inc., for the treatment of candidemia and invasive candidiasis. The seven-year period of marketing exclusivity provided through orphan designation combined with an additional five years of marketing exclusivity provided from the previously announced QIDP designation gives CD101 IV for a... […]
DAVID MCCONKEY was appointed director of the Johns Hopkins Greenberg Bladder Cancer Institute, which includes members of the Sidney Kimmel Comprehensive Cancer Center, the James Buchanan Brady Urological Institute, and the school of medicine’s departments of Radiation Oncology and Molecular Radiation Sciences, Surgery, and Pathology. The institute was established in 2014 with a $15 million... […]
